PERCEVAL S Valve Clinical Study for Chinese Registration

NAActive, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

September 25, 2020

Study Completion Date

February 25, 2024

Conditions
Aortic Valve DiseaseAortic Valve Stenosis
Interventions
DEVICE

Aortic Valve Replacement with Perceval S sutureless heart valve

Patients will be treated with the PERCEVAL S heart valve (PERCEVAL S valve) which is a bioprosthesis manufactured with bovine pericardium and assembled on a Nitinol stent. The PERCEVAL S valve is designed to offer an alternative to surgically implanted flexible prostheses (stented and stentless biological valves). A special feature of the device is that it is self-anchoring and does not require sutures to be fixed to the implant site.

Trial Locations (1)

Unknown

Fuwai Hospital CAMS&PUMC, Beijing

All Listed Sponsors
lead

Corcym S.r.l

INDUSTRY

NCT03481387 - PERCEVAL S Valve Clinical Study for Chinese Registration | Biotech Hunter | Biotech Hunter